ABCA1 Antibody (Rabbit mAb) [E4K4]

Catalog No.: F9784

    Application: Reactivity:
    • Lane 1: HepG2, Lane 2: U-87 MG
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%
    転写条件(ウェット): 250 mA, 180 min

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    254 kDa
    ポジティブコントロール Hep G2 cells; NCI-H2052 cells; U-87 MG cells
    ネガティブコントロール SH-SY5Y cells; IGROV-1 cells; HCT 116 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 250 mA, 180 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    ABCA1 Antibody (Rabbit mAb) [E4K4] detects endogenous levels of total ABCA1 protein.
    タンパク質の局在
    細胞膜、エンドソーム、細胞内膜系
    Uniprot ID
    O95477
    Clone
    E4K4
    Synonym(s)
    ABC-1; ABC1; ABCA1; ATP binding cassette subfamily A member 1; ATP-binding cassette 1; CERP; Cholesterol efflux regulatory protein; FLJ14958; HDLCQTL13; HDLDT1; HPALP1; membrane-bound; MGC164864; MGC165011; TGD
    Background
    ATP-binding cassette transporter A1 (ABCA1) belongs to the ABC transporter superfamily and functions as an integral membrane protein regulating cellular cholesterol and phospholipid homeostasis through ATP-dependent substrate translocation across plasma membranes. ABCA1 contains two transmembrane domain bundles, each comprising six membrane-spanning helices, two cytoplasmic nucleotide-binding domains responsible for ATP hydrolysis that powers transport, and a C-terminal PDZ domain mediating protein-protein interactions alongside a VFVNFA motif essential for lipid efflux activity. The protein mediates cholesterol and phospholipid efflux to lipid-poor apolipoproteins, predominantly apolipoprotein A-I (apoA-I) and apolipoprotein E (apoE), through a multi-step process initiating with the formation of specialized cell surface lipid domains enriched in cholesterol and phospholipids. Apolipoprotein binding to ABCA1 triggers conformational changes activating multiple downstream signaling cascades, including Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3), protein kinase A (PKA), Rho family GTPase CDC42, and protein kinase C (PKC), positioning ABCA1 as both a lipid transporter and a signaling receptor. PKA and CDC42 activation directly regulates ABCA1-mediated lipid efflux by modulating transporter conformation and membrane dynamics, while PKC phosphorylation stabilizes ABCA1 protein by reducing its degradation, and JAK2/STAT3 signaling controls both lipid efflux efficiency and anti-inflammatory responses. The interaction between apoA-I and ABCA1 solubilizes membrane cholesterol and phospholipids, generating nascent high-density lipoprotein (nHDL) particles that serve as acceptors for additional free cholesterol from peripheral cells, with subsequent lecithin:cholesterol acyltransferase-mediated esterification converting nHDL to mature HDL that transports cholesterol to the liver for biliary secretion and fecal excretion, constituting the reverse cholesterol transport pathway. ABCA1 executes anti-inflammatory functions independent of cholesterol efflux by modifying lipid raft composition within cell membranes, which alters Toll-like receptor 4 (TLR4) signaling and reduces expression of inflammatory cytokines and chemokines in macrophages, linking sterol efflux activities to immunomodulatory effects. The transporter exhibits ubiquitous tissue expression with particularly high abundance in liver, small intestine, and adipose tissue where lipid turnover predominates, and regulatory control occurs through transcriptional mechanisms involving liver X receptor (LXR) activation by oxysterols and through post-translational modifications, including calpain-mediated proteolysis that degrades ABCA1 protein. ABCA1 regulates membrane cholesterol content in skeletal muscle transverse tubules, modulating insulin-dependent GLUT4 translocation and glucose uptake, with reduced ABCA1 expression causing cholesterol accumulation that impairs insulin signaling through decreased Akt phosphorylation at Ser473. Loss-of-function mutations in ABCA1 cause Tangier disease, an autosomal recessive disorder characterized by severely reduced high-density lipoprotein cholesterol levels, cholesteryl ester accumulation in tissue macrophages, producing enlarged orange tonsils, hepatosplenomegaly, peripheral neuropathy, and accelerated atherosclerosis resulting from impaired reverse cholesterol transport. ABCA1 genetic variants associate with late-onset Alzheimer's disease risk, with altered ABCA1 function potentially influencing amyloid-β metabolism through effects on cellular cholesterol distribution and apoE lipidation status that modulate amyloid precursor protein processing and Aβ clearance.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください